![](https://medicaldialogues.in/h-upload/2023/05/25/210450-empagliflozin.webp)
SGLT2 inhibitors reduce arrhythmias risk in patients with type 2 diabetes: BMC study
A new study published in the recent issue of BMC Cardiovascular Diabetology journal found that in individuals with type 2 diabetes who received an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator (ICD/CRT-D), …